T cell repertoire sequencing as a cancer's liquid biopsy—can we decode what the immune system is coding?
Authors:
- Tom SnirTSTom Snir
- Sol EfroniSESol Efroni
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Current Opinion in Systems Biology
- Vol. 24, 135-141
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation (582/19, 2019090)
- United States - Israel Binational Science Foundation
- United States-Israel Binational Science Foundation
- Israel Cancer Research Fund
This publication has 43 references indexed in Scilit:
- Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast CancerJAMA Oncology, 2018
- Application of Cell-free DNA Analysis to Cancer TreatmentNew England Journal of Medicine, 2018
- Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detectionBMC Medicine, 2018
- TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinomaCancer Immunology, Immunotherapy, 2018
- TCR repertoire intratumor heterogeneity of CD4+ and CD8+ T cells in centers and margins of localized lung adenocarcinomasInternational Journal of Cancer, 2018
- Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillanceNature Communications, 2017
- System-wide Analysis of the T Cell ResponseCell Reports, 2016
- Age-Related Decrease in TCR Repertoire Diversity Measured with Deep and Normalized Sequence ProfilingThe Journal of Immunology, 2014
- High TCR diversity ensures optimal function andhomeostasis of Foxp3+ regulatory TcellsEuropean Journal of Immunology, 2011
- The case for early detectionNature Reviews Cancer, 2003